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Abstract 
Objective: We describe the prevalence of pain and its associations with healthcare resource 
utilisation and quality-of-life. 
Design: The POPPY Study recruited three cohorts: older PLWH (≥50 years, n=699), younger 
demographically/lifestyle similar PLWH (<50 years, n=374) and older 
demographically/lifestyle similar HIV-negative (≥50 years, n=304) people from April 2013-
February 2016.   
Methods: Current pain and pain-related healthcare use was collected via a self-reported 
questionnaire.  Logistic regression assessed between-group differences in the prevalence of 
pain in the past month and current pain after controlling for potential confounders.  
Associations between current pain and healthcare resource use, reported joint problems, 
depressive symptoms, quality-of-life and functional status were assessed in PLWH using 
Mann-Whitney U and Chi-squared tests. 
Results: Pain in the past month was reported by 473/676 (70.0%) older PLWH, 224/357 
(62.7%) younger PLWH and 188/295 (63.7%) older HIV-negative controls (p=0.03), with 
current pain reported in 330 (48.8%), 134 (37.5%) and 116 (39.3%), respectively (p=0.0007). 
Older PLWH were more likely to experience current pain, even after adjustment for 
confounders.  Of those with pain in the past month, 56/412 (13.6%) had missed days of work 
or study due to pain, and 520 (59%) had seen a doctor about their pain.  PLWH experiencing 
current pain had more depressive symptoms, poorer quality-of-life on all domains, and 
greater functional impairment, regardless of age group.  
Conclusions: Even in the effective ART era, pain remains common in PLWH and has a 
major impact on quality-of-life and associated healthcare and societal costs.  Interventions are 
required to assist clinicians and PLWH to proactively manage pain. 
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Introduction 
The widespread use of antiretroviral treatment (ART), and an increased focus on engagement 
and retention in care, has meant that people living with HIV (PLWH) in many parts of the 
world now have a near-normal life expectancy, particularly if a good CD4 cell count response 
and undetectable viral load are achieved on ART [1,2]. However, the cohort of PLWH is 
ageing: for example, recent data from the Netherlands suggest that by 2030, almost three-
quarters of PLWH will be aged 50 years or older, with the prevalence of age-associated co-
morbidities (such as cardiovascular disease, diabetes, chronic kidney disease, osteoporosis 
and non-AIDS malignancies) and use of concomitant medications also expected to increase 
[3].  
Moderate or severe pain has, in some studies, been reported to be one of the most common 
physical symptoms among PLWH, with reported prevalence ranging from 30% to 83% [4-8], 
and reports of high rates of several pain-related conditions among PLWH in Western 
countries [9-12].  Pain among PLWH has both clinical and public health importance.  Not 
only is pain associated with psychological distress, emotional problems, poor quality-of-life 
and suicidal ideation [13-17], but it is also known to impact on activities of daily living [18] 
and is associated with higher rates of sick leave, job loss and lower satisfaction with health 
care [19].  Among PLWH, pain is associated with poorer adherence to ART [20, 21], higher 
rates of viral load rebound [22], treatment switching [23, 24] and, in some subgroups, missed 
clinic visits [25].  Furthermore, PLWH in pain are more likely to experience lack of social 
support [26] and to be involved in risky behaviours such as alcohol use, intravenous drug use 
and sexual risk taking [6, 27-30].  Thus, in addition to the burdens placed on both the 
individual and the healthcare/social system, pain in PLWH has the potential to seriously 
curtail attempts to eliminate new HIV infections.  
Despite this, chronic pain is, however, mostly neglected in clinical practice and little research 
has been conducted on the topic in the modern ART era among individuals in whom HIV 
infection is largely controlled.  Yet, effective interventions for pain are available which could 
lead to substantial benefits if used appropriately.  We describe the prevalence of pain, 
associated factors and association with healthcare resource utilisation and quality-of-life 
among PLWH and demographically and behaviourally similar HIV-negative controls.  
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Methods 
POPPY is a prospective cohort study at seven clinical sites in the UK and Ireland that aims to 
investigate the impact of HIV on the development and outcomes of comorbidities and 
pharmacotherapy among older PLWH [31]. Three sub-groups are studied within POPPY: 
older HIV-positive (≥50 years old, n=699), younger HIV-positive (<50 years, n=374) and 
older HIV-negative (≥50 years old, n=304) people.  Eligible HIV-positive participants 
acquired HIV through sexual transmission (either sex between men or sex between men and 
women – those acquiring HIV through other routes, including injection drug use, were 
excluded), were cisgender, and were either of white or black African ethnicity.  Those 
recruited to the younger group of PLWH were frequency-matched to the group of older 
PLWH on gender, ethnicity, sexual orientation and participating clinic.  HIV-negative 
participants were required to have a documented negative HIV testing; this group was 
frequency-matched to the older PLWH group on age, gender, ethnicity, sexual orientation 
and geographical location (in or out of London).   The study was approved by the UK 
National Research Ethics Service (NRES; Fulham, London, UK; reference number 
12/LO/1409) and written informed consent was obtained from all participants. 
The POPPY dataset includes information on socio-demographics, pharmacotherapy, family 
history, medical history, healthcare utilisation and quality-of-life. The POPPY dataset is 
linked to the UK Collaborative HIV Cohort (UK sites [32]) and to the UCD ID Cohort 
(Dublin [33]) for historic data on ART and longitudinal data on CD4 counts and HIV RNA.  
A self-completed questionnaire [5] asks about experience of aches or pains that have lasted 
one day or longer in the past month, whether the pain is current, the bodily site of any pain, 
whether it has resulted in any missed days from work, or whether it has resulted in the 
participant consulting their family doctor; responses to each of these questions are either 
‘yes’ or ‘no’.  Information on pain and related resource-use is also available through the data 
captured on concomitant medication use (including specific use of a range of analgesics, 
reported as free-text), self-reported medical conditions (including a history of joint problems, 
joint inflammation, rheumatoid/osteo-arthritis, joint replacement, aches/pains and back pain), 
and reported visits to the GP, pain clinics or other specialist services for reasons relating to 
pain over the past year.  Information on quality-of-life is collected via the SF-36 
questionnaire [34], with depressive symptoms assessed through use of the Center for 
Epidemiologic Studies Depression (CES-D) questionnaire [35] (score >16 indicative of 
significant depression), and Patient Health Questionnaire-9 (PHQ-9) questionnaire [36] 
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(score >5 indicative of current depression).  The Lawton Instrumental Activities of Daily 
Living (IADL) questionnaire [37] is used to assess functional status; participants are 
considered as fully functional if they have a score of >8 on this scale.  The present analyses 
used cross sectional data from the baseline POPPY visit only, conducted between April 2013 
and February 2016.   
Statistical analysis 
The proportions of participants in the three POPPY study groups reporting any aches and 
pains in the past month, and reporting current pain, were compared using Chi-squared tests 
and logistic regression, with and without adjustment for gender, sexuality, race, educational 
level and body mass index (BMI, calculated as weight/height2) all assessed at the baseline 
visit.  Although we also describe associations with working status, this was not incorporated 
into multivariable regression analyses due to the difficulties in assessing the direction of any 
association.  Associations of current pain with quality-of-life, depressive symptoms and 
IADL in the subgroup of PLWH were assessed using Mann Whitney U tests and Chi-squared 
tests, after stratification by age group (these analyses did not include the group of HIV-
negative controls given the strong impact of HIV infection on these outcomes).  All analyses 
were performed using SAS v9.3 (SAS Institute Inc., Cary, NC).    
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Results 
Prevalence of pain 
Information on pain was available for 1325 of the 1377 (96.2%) POPPY participants (Table 
1), 676 of older PLWH, 357 younger PLWH and 292 HIV-negative controls.  Those for 
whom information on pain was available were more likely to be male (81.1% vs. 65.4%, 
p=0.008), men who have sex with men (MSM, 70.6% vs. 53.9%, p=0.02), of white ethnicity 
(86.1% vs. 65.4%, p=0.0001), and had been recruited in the earlier years of the study (58.4% 
recruited in 2013/2014 vs. 44.2%, p=0.04).  Furthermore, the median age of those with 
information on pain was slightly lower at 54 years vs. 51 years in those without information 
on pain (p=0.05).  Among PLWH, 1011 (97.9%) of those with pain information available 
were on ART, 925 (90.0%) had a viral load <50 copies/ml, and median latest and nadir CD4 
counts were 626 and 203 cells/mm3, respectively, with no significant differences from those 
without information available. 
The prevalence of reported aches and pains in the last month was 66.6% (882/1325) and was 
significantly higher in older PLWH (473/676, 70.0%) than in either younger PLWH 
(224/357, 62.7%) or older HIV-negative controls (188/295, 63.7%, p=0.03).  Those who 
reported pain in the past month were more likely to be female (p=0.01), heterosexual 
(p=0.02), of black African ethnicity (p=0.01) and were slightly older (p=0.01) than those not 
reporting pain (Table 1).  Those reporting pain in the past month also had lower educational 
attainment (p=0.002) than those not reporting pain in the past month. In unadjusted analyses, 
and compared to older PLWH, the odds of reporting aches or pains in the last month was 
28% lower in younger PLWH, and 26% lower in HIV-negative controls (Figure 1a); after 
adjustment for potential confounding factors, associations between the three groups remained 
significant (Figure 1a).  
Of those reporting pain in the past month, pain was reported to be current in 580 (43.8% of 
those with information on pain, Table 1).  Current pain was again more common in the older 
PLWH (330/676, 48.8%) than in younger PLWH (134/357, 37.5%), or older HIV-negative 
controls (116/292, 39.7%).  Associations with demographic factors, work and educational 
status were broadly similar to those seen for any pain in the past month.  In unadjusted 
analyses, and compared to older PLWH, the odds of reporting current pain was 37% lower in 
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younger PLWH and 31% lower in HIV-negative controls (Figure 1b) with associations again 
remaining significant after adjustment for potential confounders (Figure 1b).   
In the two groups of PLWH, of the HIV factors, only a lower nadir CD4 count was associated 
with an increased risk of either pain in the past month or current pain in the two groups of 
PLWH, with no associations being seen with either ART exposure or current CD4 count 
(Table 1).  Adjustment for nadir CD4 count did not modify the association between age group 
and either any pain in the past month or current pain in PLWH (Figures 1a/b). 
Impact of pain on daily activities and resource use 
Of those reporting pain who provided a response, 13.6% (56/412) reported having missed 
days of work or study due to the pain; 18.9% (30/159) in older PLWH, 12.2% (17/139) in 
younger PLWH and 7.9% (9/114) in HIV-negative controls (p=0.03).  When we compared 
current work status, only 41.7% of those reporting current pain were working full-time, 
compared to 62.7% of those not reporting current pain.  Whilst similar (small) proportions in 
the two groups were students (1.4% vs. 1.1%, respectively), 30% of those reporting current 
pain were unemployed or on sick leave (vs. 14.8% in those not reporting current pain) and 
26.9% were classified as having other or unknown work status (vs. 21.5% of those not 
reporting current pain, global p=0.0001).  Fifty-nine percent of participants had seen a doctor 
about their pain (295 (62.4%), 110 (49.1%) and 115 (62.2%) in the three groups respectively, 
p=0.002).  Pain-related resource use is shown in Table 2.  Reported analgesic use was more 
common in older PLWH than in the other two groups.  Although there were significant 
between-group differences in reported joint problems, GP visits and any pain-related resource 
use, these differences appeared to be driven more by older age than by HIV status.  GP visits 
for pain were lower in the two groups of PLWH than in HIV-negative controls. 
PLWH experiencing current pain had significantly higher scores on both CES-D and PHQ-9, 
regardless of age group, reflecting greater levels of depressive symptoms (Table 3).  Almost 
all domains of quality-of-life were poorer in those experiencing current pain than in those 
without current pain.  Individuals in both age groups experiencing current pain were also less 
likely to be classified as fully functional on the Lawton IADL score. 
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Discussion 
Despite the use of more modern ART regimens, older PLWH continue to experience higher 
rates of pain than similarly-aged HIV-negative participants.  Interestingly, whilst younger 
PLWH also reported a high rate of pain, this was at a similar level to that seen among the 
older HIV-negative participants.  In all three groups, pain was associated with lower 
employment rates and with high levels of healthcare resource use.  Among the two groups of 
PLWH, current pain was associated with higher depressive symptoms, poorer quality-of-life 
and poorer functional status, regardless of age.   
Pain has frequently been reported to be one of the most common symptoms among PLWH, 
particularly in the pre- and early-combination ART eras.  In a review article of 28 studies 
published from 1993-2011, Parker [6] reported a weighted point prevalence of pain of 54% 
and a three-month pain prevalence rate of 83%.  Whilst more recent years have seen 
improvements in both the efficacy of ART, and the range of ART drugs that are available for 
use, pain continues to be frequently reported [4, 5, 8].  Among participants in the Women’s 
Interagency HIV Study (WIHS), 56.1% indicated experiencing pain for at least 6 days over 
the past 6 months, with one in ten participants reporting experiencing pain for >120 days and 
over a third reporting experiencing extreme pain at least once over the period [38].  Pain in 
PLWH is also complex; in one study of attendees at a primary care clinic in New York City 
[39], the most common pain disorders reported were musculoskeletal pain, followed by 
neuropathic pain, headaches (including migraine), other poorly defined pain syndromes and 
chronic pelvic pain; multiple chronic pain diagnoses are commonly reported [5, 40].  Whilst 
it is tempting to attribute some of this high prevalence of pain to HIV infection, other causes 
may also be common – for example, among indigenous adults in San Francisco in the 
Research on Access to Care in the Homeless (REACH) study [41], physical assault and living 
conditions were commonly cited as causes of pain.   
Whilst we did not aim to identify specific risk factors for current pain, pain was more 
commonly reported in women who, in our study, were also more likely to have acquired HIV 
infection through sex with men and to be of black African origin, and in those of lower 
educational attainment.  Associations with gender in the published literature have been 
inconsistent [4,6,41], but lower educational levels have been reported to be associated with an 
increased prevalence of pain [41].  Older age is generally associated with an increased risk of 
pain as well as greater pain severity [5, 38, 39], consistent with our own findings.  An 
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association of pain with more advanced HIV infection (as expressed by lower current/nadir 
CD4 counts, higher HIV viral loads and/or longer duration of HIV infection) has been 
reported previously [4, 5, 38].  
Findings regarding other pain-related markers were somewhat less consistent.   Whilst 
analgesic use was more common in older PLWH, joint problems occurred at a similar rate in 
both older groups in our study.  Although a high proportion of participants had consulted a 
doctor about their pain (with no large differences between the two older groups in the study), 
visits to the GP for pain-related reasons were, if anything, more common in older HIV-
negative controls, likely reflecting the fact that PLWH in the UK are under close 
management at their HIV clinic and are more likely to consult their HIV consultant for issues 
relating to pain than they are to consult a GP (HIV care in the UK is generally provided by 
hospital specialists). Other studies have reported high rates of healthcare resource use due to 
pain [5, 39, 42].  In a study of 103 people with HIV-related neuropathic pain [42], 
participants had been prescribed an average of 0.7 non-prescription pain-related medications 
(antiepileptics and opioids being most common) over the past 4 weeks with around 20% 
having received 3 or more such medications.  Among primary care attendees in New York 
City [39], those reporting chronic pain had more emergency department visits and more 
radiology procedures with a trend towards a greater number of inpatient admissions.  These 
studies did not generally make comparisons to a similar HIV-negative control group, and 
therefore it is unclear whether pain-related resource use in PLWH is any higher than would 
be expected in a similarly aged group in the general population. In one study of veterans with 
and without HIV in the United States [43], 13% of participants reported nonmedical use of 
prescription opioids, although in adjusted analyses no association was reported with HIV 
status.  
Whilst only a small proportion of participants reported missing days of work or study due to 
pain, those with pain were less likely to be in full-time work and more likely to be 
unemployed or off sick than those without pain.  An impact on work has been reported in 
other studies: Mann reported that among those with neuropathic pain, there was a 36.1% 
overall work impairment due to the pain which increased with increasing pain severity [42].  
Total unadjusted annualized costs due to HIV-related neuropathic pain ranged from $9,900 to 
$25,822 per person, depending on the severity of the pain.   
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Among PLWH, we noted strong associations between the presence of pain and depressive 
symptoms, quality-of-life and functional impairment, regardless of age, as reported in other 
studies [5, 8, 42, 44].  Merlin [17] reported that current pain was associated with impairments 
in mobility, self-care and usual activities.  A causal association between pain and interference 
with daily activities is supported by findings from a randomised trial of a pain education 
intervention, in which those randomised to the intervention experienced reduced pain 
interference with daily activities after an 8-week period [45].  Associations with substance 
use have also been reported [8, 38, 39], with pain serving both as a mediator and as a 
predictor of more use of recreational drugs, as well as more depressive symptoms [46].  Other 
negative effects of pain include direct associations with reduced social support [26] and with 
higher rates of unprotected vaginal or anal sex [29], raising concern that pain in PLWH may 
also lead to worse outcomes on ART.  Whilst we were unable to consider this association in 
our cross-sectional analysis (the majority of POPPY participants were on stable ART at 
recruitment), Surratt [7] reported that those with untreated pain had a 42% lower odds of 95% 
medication adherence in the previous week compared to those who were pain-free. 
As yet, the mechanisms by which HIV may lead to an increased risk of pain remain unclear.  
In 2013, Merlin [47] proposed a conceptual biopsychosocial framework for understanding 
chronic pain in PLWH, which includes biological (such as HIV neuropathy), psychological 
(following traumatic events) and social (environmental and relationship) factors.  More 
recently [48], Merlin noted significantly higher levels of IL-1β a marker already implicated in 
a range of inflammatory and autoimmune diseases, in PLWH with chronic pain than in those 
without chronic pain, suggesting a biological pathway. Thus, interventions to reduce the 
burden of pain in this population need to address both physical and psychological factors. 
Whilst there is some evidence to suggest that self-management interventions may be effective 
in improving pain and physical symptoms, the quality of evidence to support these 
interventions is relatively poor [49].  A recent pilot study [50] has, however, demonstrated 
feasibility and acceptability of such an approach.  
The large sample of PLWH in our study is broadly representative of older PLWH in western 
European settings, where the population is optimally treated for their HIV (with high levels 
of viral suppression).  This has allowed us to describe the prevalence of pain among PLWH 
in an era of very effective treatment.  In comparison to many earlier studies, our study also 
benefits from the inclusion of appropriately selected HIV-negative controls with similar 
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characteristics to the older PLWH in the study, allowing us to determine the role of HIV 
infection in the development of pain.  Indeed, our study also reports a high prevalence of pain 
in older HIV-negative people from a similar demographic background and with similar 
lifestyles – thus, the contribution of HIV itself to the high reported rate of pain in PLWH may 
be less than widely thought, with other contributory causes being common in this age group.  
However, some limitations must be noted.  Firstly, whilst the POPPY study is a prospective 
cohort, the analyses reported herein relate to the baseline visit only limiting inferences around 
causality - future analyses of the longitudinal follow-up of this cohort will permit more 
detailed analyses of the impact of pain on longer-term general and health-related outcomes as 
well as the identification of predictors (both HIV-related and HIV-unrelated) of incident and 
chronic pain.  Due to the observational nature of the study, we cannot rule out the possibility 
that unmeasured common causes of pain and negative health outcomes may exist, which may 
introduce confounding. Whilst our cohort is broadly representative of the older population of 
PLWH in the UK and Ireland, the fact that most participants are engaged in care and are on 
stable ART may have introduced some selection bias; equally, this population may represent 
a cohort that has ‘survived’ through earlier eras of ART and may not be representative of 
those who are infected with HIV in more recent years.   
Conclusions 
Our study confirms that even in the era of effective ART, and in individuals with largely 
controlled HIV infection, pain remains common among PLWH with major impact on quality-
of-life and associated healthcare and societal costs.  Interventions are required to assist 
clinicians to proactively manage pain in their patients, and to assist PLWH to communicate 
their pain to clinicians and to self-manage pain and related symptoms. Our findings support 
the need for routine assessment of pain in this group.  Further longitudinal studies of the 
severity, location and contributors to pain in PLWH will support the development of 
effective, low cost and easy to manage interventions for pain management.  
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Table 1: Characteristics of a) all POPPY participants included in the analysis of pain data, b) 
those who do and do not report pain in the last month, and c) those who do and do not report 
current pain; table entries show n and column percentages, unless otherwise stated 
* P-
value obtained from Chi-squared test (categorical covariates) or Mann-Whitney U test 
(continuous covariates) 
MSM: men who have sex with men; IQR: interquartile range.   
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Table 2: Other markers of pain assessed as part of the baseline POPPY study visit, stratified 
by study group 
  Group  
 Overall Older HIV-
positive 
Younger 
HIV-positive 
Older HIV-
negative 
p-value 
(Chi-
squared 
test) 
Number of 
participants 
1377 699 374 304  
Concomitant 
medication 
     
Any reported 
analgesic use 
210 
(15.3) 
130 (18.6) 49 (13.1) 31 (10.2) 0.001 
Reported health 
problems 
     
Any joint problem 629 
(45.7) 
371 (53.1) 108 (28.9) 150 (49.3) 0.0001 
Resource use      
GP – generalised 
pain 
22 (1.6) 10 (1.4) 7 (1.9) 5 (1.6) 0.86 
GP – back pain 65 (4.7) 28 (4.0) 16 (4.3) 21 (6.9) 0.12 
GP – joint pain 
problems 
104 
(7.6) 
50 (7.2) 21 (5.6) 33 (10.9) 0.03 
GP – other pain 112 
(8.1) 
58 (8.3) 27 (7.2) 27 (8.9) 0.71 
Any GP visit for 
pain-related reasons 
264 
(19.2) 
128 (18.3) 59 (15.8) 77 (25.3) 0.005 
Any GP visits 1052 
(76.4) 
547 (78.3) 260 (69.5) 245 (80.6) 0.0009 
Median (range) 
number of GP visits 
2 (1-32) 2 (1-32) 2 (1-23) 2 (1-20) 0.09 
Other specialist – 
pain management 
19 (1.4) 14 (2.0) 2 (0.5) 3 (1.0) 0.12 
Any pain-related 
resource use 
274 
(19.9) 
136 (19.5) 59 (15.8) 79 (26.0) 0.004 
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Table 3: Association between current pain, depression scores (CES-D, PHQ9) and 
components of quality-of-life (SF-36) 
 among PLWH, stratified by age group 
 PLWH aged >50 
years 
p-
value2 
PLWH aged <50 years p-
value2 
 No 
current 
pain 
Current 
pain 
No current 
pain 
Current 
pain 
Depressive symptoms1       
CES-D score, median 
(IQR) 
9 (3, 17) 15 (7, 
26) 
0.0001 7 (3, 15) 14 (7, 27) 0.0001 
Significant depression 
(>16), n (%)  
92 (28.5) 148 
(50.0) 
0.0001 51 (24.6) 57 (46.3) 0.0001 
PHQ-9 score, median 
(IQR) 
2 (0, 7) 7 (2, 
12) 
0.0001 3 (1, 7) 6 (2, 13) 0.0001 
Current depression 
(>5), n (%) 
120 
(36.6) 
183 
(60.2) 
0.0001 85 (39.9) 73 (57.5) 0.002 
Quality of life (SF-36 
subscales)1, median 
(IQR) 
      
Physical functioning 90 (75, 
100) 
72 (45, 
90) 
0.0001 100 (95, 
100) 
90 (55, 
100) 
0.0001 
Role limitations due 
to physical health 
100 (50, 
100) 
50 (0, 
100) 
0.0001 100 (100, 
100) 
75 (0, 
100) 
0.0001 
Role limitations due 
to emotional 
problems 
100 (33, 
100) 
83 (0, 
100) 
0.0002 100 (66, 
100) 
67 (0, 
100) 
0.0001 
Energy/fatigue 65 (50, 
80) 
50 (25, 
65) 
0.0001 65 (50, 80) 50 (30, 
65) 
0.0001 
Emotional well-being 80 (60, 
88) 
68 (52, 
84) 
0.0001 80 (60, 88) 68 (52, 
84) 
0.001 
Social functioning 90 (65, 
100) 
67 (42, 
90) 
0.0001 90 (67, 
100) 
67 (42, 
90) 
0.0001 
General health 70 (55, 
80) 
50 (30, 
70) 
0.0001 75 (55, 85) 60 (40, 
75) 
0.0001 
Lawton Instrumental 
Activities of Daily Living 
      
Fully functioning, n 
(%) 
302 
(91.0) 
241 
(76.5) 
0.0001 205 (95.4) 98 (77.2) 0.0001 
1For CES-D and PHQ-9, higher values indicate greater depressive symptoms; for the sub-
scales of the SF-36, lower values indicate  
poorer quality of life. 2p-values obtained from Mann-Whitney U test (numerical outcomes) or 
Chi-squared test (categorical outcomes) 
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